HEXA-BETALIN Drug Patent Profile
When do Hexa-betalin patents expire, and when can generic versions of Hexa-betalin launch?
Hexa-betalin is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in HEXA-BETALIN is pyridoxine hydrochloride. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the pyridoxine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hexa-betalin
A generic version of HEXA-BETALIN was approved as pyridoxine hydrochloride by FRESENIUS KABI USA on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HEXA-BETALIN?
- What are the global sales for HEXA-BETALIN?
- What is Average Wholesale Price for HEXA-BETALIN?
Summary for HEXA-BETALIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 147 |
| Patent Applications: | 4,118 |
| DailyMed Link: | HEXA-BETALIN at DailyMed |
US Patents and Regulatory Information for HEXA-BETALIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | HEXA-BETALIN | pyridoxine hydrochloride | INJECTABLE;INJECTION | 080854-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
